Long-term follow-up study of SWEDD patients with mild parkinsonian signs

S Sasaki - BMJ Neurology Open, 2024 - pmc.ncbi.nlm.nih.gov
Background Whether scan without evidence of dopaminergic deficit (SWEDD) can be a
reliable indication of a clinical entity of Parkinson's disease (PD) is controversial. Objective …

Marked Decreased Tracer Binding in 123I-FP-CIT SPECT Scans From Lisdexafetamine Dismesylate Interaction: A Case Report

T Miyagawa, C Vernon, SA Przybelski… - Clinical …, 2024 - journals.lww.com
Objectives The objective of this case study is to raise awareness of potential 123 I-FP-CIT
SPECT interference by lisdexafetamine dimesylate, a prodrug of d-amphetamine. Methods A …

Structural insight of MODAG-005 on 𝛼 -Synuclein aggregates as a novel PET tracer

M Kim - 2024 - ediss.uni-goettingen.de
Neurodegenerative disorders, including Parkinson's disease (PD) and related
synucleinopathies, are characterized by the accumulation of pathological protein …

Doprinos slikovne dijagnostike dopaminskih transportera u dijagnostici parkinsonizma

I Đolonga - 2024 - repository.medri.uniri.hr
Sažetak Uvod: Slikovna dijagnostika dopaminskih transportera podrazumijeva SPECT s
radiofarmakom 123I-ioflupanom, a naziva se još i DaTscan. Najčešće se koristi u …